Global Cancer Research Map | International Research Context
Global Cancer Research — Evidence Context Overview
Understanding how oncology research, clinical trials, and evidence generation occur across countries and healthcare systems
This page provides an educational overview of global oncology research activity as reflected in peer-reviewed literature, international clinical trials, and institutional research output.
It does not provide treatment access, referrals, or recommendations.
Click any marker to explore that country's research achievements
Research Indicators Context
Country-level summaries are based on publicly referenced research indicators (e.g., publication output, trial registry activity, research infrastructure, and institutional visibility in oncology literature). Rankings are illustrative and do not imply treatment superiority, patient suitability, access to care, or outcome differences for individuals.
Update Note: Research indicators may lag real-world changes by months and are updated as source databases refresh.
Countries grouped by research indicators and visibility • Click to view detailed achievements
China
China Leads Global Cancer Research Output
- •China overtook the United States in cancer research output in 2024, marking a 19% increase in share.
- •The country has become a leader in global clinical drug trials, with over 7,100 trials listed in 2024.
- •China's biotech sector has seen significant growth, with 37% of licensed drug compounds sourced from the country.
- •China is a member of the International Cancer Genome Consortium, focusing on gastric cancer research.
- •China is a member of the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries, aiming to improve cancer care access.
- •China is a member of the International Cancer Genome Consortium, focusing on gastric cancer research.
United States
Oncology Research Across U.S. Institutions and States
- •NCI-designated cancer centers conduct laboratory, clinical, prevention, and population research across the United States.
- •National research networks coordinate cancer clinical trials across participating institutions and communities.
- •Research activity varies by state, institution, cancer type, and population—making regional evidence and research gaps important to examine.
United Kingdom
UK's Pioneering Cancer Research Initiatives
- •The international SERENA-6 phase III trial, co-led by researchers at the Institute of Cancer Research and Royal Marsden, studied whether blood tests detecting emerging ESR1 mutations could guide an earlier treatment change for a defined group of patients with advanced breast cancer. The reported results showed a delay in disease progression.
Germany
Germany's Advancements in Pediatric Cancer Research
- •Germany is a member of the International Cancer Genome Consortium, focusing on pediatric brain tumors.
- •Germany is a member of the International Cancer Genome Consortium, focusing on pediatric brain tumors.
- •Germany is a member of the International Cancer Genome Consortium, focusing on pediatric brain tumors.
Japan
Japan's Innovations in Cancer Treatment
- •In May 2026, Japan approved alectinib for specified advanced or recurrent ALK-fusion-positive solid tumors, including eligible pediatric patients. Research through National Cancer Center Japan's MASTER KEY project helped support this biomarker-based approval.
Sweden
Sweden's Contributions to Cancer Genomics
- •Sweden is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
- •Sweden is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
- •Sweden is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
Canada
Canada's Leadership in Cancer Research
- •Canada is a member of the International Cancer Genome Consortium, focusing on pancreatic and prostate cancers.
- •Canada is a member of the International Cancer Genome Consortium, focusing on pancreatic and prostate cancers.
- •Canada is a member of the International Cancer Genome Consortium, focusing on pancreatic and prostate cancers.
Netherlands
Netherlands' Advances in Cancer Diagnostics
- •The Netherlands is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
- •The Netherlands is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
- •The Netherlands is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
Singapore
Singapore's Role in Cancer Research Collaborations
- •Singapore is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
- •Singapore is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
- •Singapore is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
Denmark
Denmark's Innovations in Cancer Treatment
- •Denmark is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
- •Denmark is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
- •Denmark is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
France
France's Pioneering Cancer Research Efforts
- •The international phase III NIVOPOSTOP trial, coordinated in France with Gustave Roussy involvement, studied the addition of nivolumab after surgery for high-risk head and neck cancer. It reported improved three-year disease-free survival; overall survival results were not yet available in the cited report.
Switzerland
Switzerland's Contributions to Cancer Genomics
- •Switzerland is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
- •Switzerland is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
- •Switzerland is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
Italy
Italy's Advances in Cancer Research
- •Italy is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
- •Italy is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
- •Italy is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
Spain
Spain's Innovations in Cancer Treatment
- •Spain is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
- •Spain is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
- •Spain is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
Australia
Australia's Leadership in Cancer Research
- •Australia is a member of the International Cancer Genome Consortium, focusing on pancreatic and ovarian cancers.
- •Australia is a member of the International Cancer Genome Consortium, focusing on pancreatic and ovarian cancers.
- •Australia is a member of the International Cancer Genome Consortium, focusing on pancreatic and ovarian cancers.
Israel
Israel's Innovations in Cancer Treatment
- •Israel is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
- •Israel is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
- •Israel is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
Taiwan
Taiwan's Contributions to Cancer Research
- •Taiwan is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
- •Taiwan is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
- •Taiwan is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
Belgium
Belgium's Role in Cancer Research Collaborations
- •Belgium is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
- •Belgium is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
- •Belgium is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
South Korea
South Korea's Advances in Cancer Diagnostics
- •South Korea is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
- •South Korea is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
- •South Korea is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
India
India's Growing Cancer Research Landscape
- •India approved NexCAR19 as its first locally developed CAR-T cell therapy for certain blood cancers. Its development involved Tata Memorial Centre and collaborators, illustrating how research and manufacturing capacity can expand access to advanced therapies.
Brazil
Brazil's Emerging Role in Cancer Research
- •Brazil is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
- •Brazil is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
- •Brazil is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
Argentina
Argentina's Contributions to Cancer Research
- •Argentina is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
- •Argentina is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
- •Argentina is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
Mexico
Mexico's Advancements in Cancer Research
- •Mexico is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
- •Mexico is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
- •Mexico is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
Finland
Finland's Innovations in Cancer Diagnostics
- •HUS launched FINACCESS in 2026 to study newer cancer medicines while collecting evidence on their effectiveness and safety. Its first planned treatment cohort concerns HER2-mutated non-small-cell lung cancer. This is an ongoing research program, not a reported treatment breakthrough.
Norway
Norway's Contributions to Cancer Research
- •Norway is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
- •Norway is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
- •Norway is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
New Zealand
New Zealand's Role in Cancer Research
- •New Zealand is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
- •New Zealand is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
- •New Zealand is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
Iceland
Iceland's Contributions to Cancer Research
- •Iceland is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
- •Iceland is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
- •Iceland is a member of the International Cancer Genome Consortium, focusing on breast cancer research.
Poland
Central European oncology hub with growing clinical trial infrastructure
- •Expanding participation in international multi-center trials
- •Strong academic oncology programs in Warsaw and Kraków
- •Emerging precision oncology capabilities
Austria
Advanced cancer research with world-class medical institutions in Vienna
- •Leading European cancer research centers
- •Strong immunotherapy and molecular oncology programs
- •Collaboration with German-speaking research networks
South Africa
Leading African cancer research with focus on regional cancer patterns
- •Pioneering research on cancers prevalent in African populations
- •Growing clinical trial infrastructure
- •Key hub for HIV-related cancer research
Kenya
Cancer Trials and Research Data in East Africa
- •Aga Khan University's Clinical Research Unit in Nairobi supports cancer clinical trials.
- •The Nairobi Cancer Registry at the Kenya Medical Research Institute also serves as an IARC center of expertise supporting cancer-registry development across sub-Saharan Africa.
Thailand
Cancer Genomics and Diagnostic Research
- •Researchers at Siriraj Hospital are developing genomic approaches to assist brain-cancer diagnosis, alongside broader oncology and clinical research.
- •Presented as research in development, not as a proven improvement in patient outcomes.
Portugal
Translational Oncology and Clinical Studies
- •The Champalimaud Clinical Centre in Lisbon conducts observational and interventional studies.
- •Research reported in cancer imaging, precision radiotherapy, radiopharmacology, and the biology of metastasis.
Ireland
National Cancer-Trials Collaboration
- •Cancer Trials Ireland coordinates a national cancer-trials network.
- •In 2026, it launched an initiative to study how Irish trial sites could reduce delays between regulatory approval and trial opening.
Explore Major Global Cancer Research Institutions
Cancer research is a global effort, driven by institutions across Europe, Asia, and beyond. These international centers play a critical role in developing new treatments, advancing immunotherapy, and leading clinical trials that shape cancer care worldwide.
This page highlights major global cancer research institutions, their scientific strengths, and how their breakthroughs support patients, clinicians, and researchers everywhere.
Inclusion reflects research activity and publication prominence, not treatment recommendation, access, or suitability for individual patients.
International institutions contributing to high-impact oncology research
Global leader in early-phase clinical trials, precision imaging, radiation oncology, and cancer genetics
Research Context:
- ✔High-volume Phase I oncology trial programs
- ✔Significant publication output in radiotherapy and imaging innovation
- ✔Partnered with ICR, a highly-cited cancer research institution
Contact information is provided for institutional identification only and does not imply access pathways or patient services.
Europe's leading immunotherapy hub, molecular oncology center, and combination therapy innovator
Research Context:
- ✔Significant publication output in immunotherapy research
- ✔Early contributor to checkpoint inhibitor and targeted therapy combination studies
- ✔Extensive genomic and precision cancer research programs
World leader in radiation oncology, imaging science, and hematologic cancers
Research Context:
- ✔High-impact research output and citation visibility
- ✔Significant contributions to AI-driven imaging and adaptive radiotherapy research
- ✔Extensive participation in leukemia, lymphoma, and stem-cell research programs
World's highest-volume cancer center with global leadership in affordable treatment models
Research Context:
- ✔High patient-volume center with extensive clinical experience
- ✔Significant research contributions to affordable treatment models
- ✔Active research programs in breast, oral, GI, and cervical cancer
Nobel Prize–affiliated research powerhouse in molecular oncology, immunology, and rare cancers
Research Context:
- ✔Nobel Prize–affiliated research institution
- ✔Significant contributions to tumor immunology research
- ✔Extensive participation in translational & molecular cancer science studies
This page helps you understand the global landscape of cancer research, showing where major discoveries, clinical trials, and innovations are taking place around the world.
Patients & Families:
Use this page to learn where cutting-edge research is happening internationally. You do not need to travel abroad to benefit from global research—many institutions publish open-access findings, and some offer remote consultation pathways that may be institution- and jurisdiction-dependent.
Clinicians:
Identify institutions leading early-phase clinical trials, immunotherapy innovations, precision oncology, and molecular research. These centers often shape global standards of care.
Researchers:
Explore global hubs of translational science, genomics, immunotherapy, and collaborative clinical trials that influence major scientific advancements.
- •Understanding how treatment innovations emerge across healthcare systems
- •Learning how regulatory and scientific communities evaluate evidence differently
- •Exploring how international clinical trials contribute to global oncology knowledge
- •Recognizing research breakthroughs and methodological innovations worldwide
- •CAR-T cell therapies for solid tumors
- •Novel immunotherapy combinations
- •Precision medicine and genetic targeting
- •Radioligand therapy innovations
For hospitals, cancer centers, researchers, trial coordinators, and academic institutions.
Stay Informed With Global Cancer Research
Get important oncology updates, clinical trial openings, and research breakthroughs delivered to your inbox.
Download the Global Oncology Market Outlook (Free Preview)
Get a free 10-page intelligence summary covering global cancer trends, breakthrough therapies, and clinical trial insights.
This preview contains aggregated research trends and does not include treatment guidance, market forecasts for individual care decisions, or investment advice.
Our global oncology data is compiled from authoritative sources to provide accurate, up-to-date information for educational purposes.
Global Research Databases
Nature Index, PubMed, Scopus, and Web of Science for peer-reviewed publications
Government Research Portals
National cancer institutes, health ministries, and regulatory agencies worldwide
Clinical Trial Registries
ClinicalTrials.gov, EU Clinical Trials Register, WHO ICTRP
Independent Curation
Summaries are independently curated for educational use by oncology research professionals
Disclaimer: Information provided is for educational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals for medical decisions.